BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab (BETH)

Clinical Trial ID NCT00625898

PubWeight™ 18.02^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00625898

Top papers